Neuraxis, Inc (NRXS): Total Liabilities

Annual figures by period end, from SEC filings.

$3.00M
As of 2025-12-31
$3.26M
As of 2026-06-30
-24.8%
3-year compound annual growth
$7.05M2022-12-31: $7.05M2023-09-30: $2.30M2023-12-31: $1.91M2024-12-31: $2.69M2025-12-31: $3.00M$3.00M
2022-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$3.00M+11.7%2026-03-19, Balance as of period end
2024-12-31$2.69M+40.6%2026-03-19, Balance as of period end
2023-12-31$1.91Mn/a2025-03-20, Balance as of period end
2023-09-30$2.30Mn/a2024-04-16, Balance as of period end
2022-12-31$7.05Mn/a2024-04-16, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Neuraxis, Inc (NRXS)2025-12-31$3.00M+11.7%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$1.26M-13.8%
Hongchang International Co., Ltd (HCIL)2024-12-31$18.68M+92.0%
Nuwellis, Inc. (NUWE)2025-12-31$3.49M+4.6%
Escalon Medical Corp (ESMC)2025-06-30$3.08M+4.4%
CapsoVision, Inc (CV)2025-12-31$4.90M+82.4%
Hyperfine, Inc. (HYPR)2025-12-31$14.26M+44.6%
Guided Therapeutics Inc (GTHP)2025-12-31$7.33M+17.0%
QT Imaging Holdings, Inc. (QTI)2025-12-31$16.58M+6.1%

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗